PLSE · Pulse Biosciences, Inc.
$35.17
-0.30 (-0.85%)
At close · Jul 29
Market Cap
$2.45B
Shares
69.21M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Paul LaViolette | CEO | $7,427,899 |
| Jon Skinner | CFO | $2,843,000 |
| Darrin R. Uecker | CTO | $869,889 |
| Kevin P. Danahy | Former Chief Commercial Officer | $854,577 |
| Mitchell E. Levinson | Board Member | — |
| Burke T. Barrett | CEO | — |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Burke T. Barrett | CEO | $8,435,605 |
| Darrin R. Uecker | CTO | $616,410 |
| Kevin P. Danahy | Former Chief Commercial Officer | $616,410 |
| Paul LaViolette | CEO | — |
| Jon Skinner | CFO | — |
| Mitchell E. Levinson | Board Member | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Kevin P. Danahy | Former Chief Commercial Officer | $5,864,450 |
| Darrin R. Uecker | CTO | $5,390,028 |
| Mitchell E. Levinson | Director and Chief Strategy Officer | $1,694,562 |
| Paul LaViolette | CEO | — |
| Jon Skinner | CFO | — |
| Burke T. Barrett | CEO | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Kevin P. Danahy | CEO | $2,263,256 |
| Darrin R. Uecker | CTO | $487,235 |
| Mitchell E. Levinson | Director and Chief Strategy Officer | $361,338 |
| Jon Skinner | CFO | — |
| Paul LaViolette | CEO | — |
| Burke T. Barrett | CEO | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Darrin R. Uecker | CTO | $2,286,036 |
| Mitchell E. Levinson | Board Member | $1,062,416 |
| Kevin P. Danahy | CEO | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Liane R. Teplitsky | Chief Operating Officer | Appointed | 2026-04-09 |
| Kevin P. Danahy | Chief Commercial Officer | Resigned | 2026-02-27 |
Key facts
CIK
1625101
CUSIP
74587B101
13F (30d)
13 filings
13 filers
Visit website
Investor relations